DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,412 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $833,204 | 0.0% | 3,510 | 0.0% | 0.14% | 0.0% |
| Q2 2023 | $833,204 | +64.0% | 3,510 | +60.6% | 0.14% | +71.1% |
| Q1 2023 | $507,947 | -9.1% | 2,185 | +3.8% | 0.08% | -2.4% |
| Q4 2022 | $558,975 | +161.2% | 2,106 | +154.0% | 0.08% | +150.0% |
| Q3 2022 | $214,000 | -0.9% | 829 | -2.7% | 0.03% | 0.0% |
| Q2 2022 | $216,000 | -90.6% | 852 | -89.1% | 0.03% | -90.6% |
| Q1 2022 | $2,299,000 | -26.6% | 7,839 | -17.6% | 0.36% | -21.6% |
| Q4 2021 | $3,132,000 | +29.9% | 9,518 | +20.1% | 0.46% | +8.2% |
| Q3 2021 | $2,412,000 | -17.0% | 7,923 | -26.8% | 0.43% | -26.4% |
| Q2 2021 | $2,906,000 | -0.9% | 10,829 | -16.9% | 0.58% | -15.9% |
| Q1 2021 | $2,932,000 | +2.2% | 13,026 | +0.8% | 0.69% | -2.0% |
| Q4 2020 | $2,870,000 | -11.0% | 12,921 | -13.7% | 0.70% | -11.3% |
| Q3 2020 | $3,225,000 | +14.2% | 14,978 | -6.2% | 0.79% | +22.0% |
| Q2 2020 | $2,824,000 | +54.6% | 15,968 | +34.2% | 0.65% | +23.5% |
| Q4 2019 | $1,827,000 | +34.8% | 11,902 | +26.8% | 0.53% | +17.9% |
| Q3 2019 | $1,355,000 | +50.7% | 9,383 | +49.1% | 0.45% | +36.7% |
| Q2 2019 | $899,000 | – | 6,291 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |